Innovating chemistry

Philochem is a Swiss subsidiary of the Philogen group, acting as discovery center with a focus on chemical pharmaceutical products and technologies. Philochem also offers its encoded library technologies to discover small molecule-, peptide-, and antibody-binders to collaboration partners.

Philogen to attend the European Association of Nuclear Medicine (EANM) annual meeting on October 19-23, 2024

Andrea Galbiati is giving a presentation about Philochem’s FAP-targeted radioligand therapeutics on October 20 (session 604), entitled “Development of Multivalent...

Philochem to attend the Festival of Biologics 2024 in Basel (15-17 October 2024)

Dr. Andrea Galbiati will give a talk entitled "Small Molecule Therapeutics targeting Fibroblast Activation Protein in the tumor microenvironment” Dr. Ettore Gilardoni...

Philochem to attend the 23rd Human Proteome Organization World Congress as presenting authors on October 20-24, 2024 in Dresden, Germany)

Philochem will participate at the 23rd HUPO Congress in October, presenting two posters: Domenico Ravazza (3rd year Ph.D. student): Mass spectrometry as a quantitative...

Philogen to attend the TIDES Europe 2022 in Vienna, Austria (16-18 November)

Philogen will attend the TIDES Europe in Vienna in November 2022. Samuele Cazzamalli, Head of Small Molecules Therapeutics at Philogen, will give a lecture entitled...

Philogen to attend the PEGS Europe 2022 on November 14-16, 2022

Dario Neri, co-founder, CEO and CSO, is giving a lecture entitled “Antibody-cytokine fusions: emerging clinical data in glioblastoma, sarcoma and dermato-oncology...

OUR SCIENCES

Learn about our strategy

PIPELINE

Learn more about our pipeline

WORK WITH US

Look at open positions